Hodaj Hasan, Payen Jean-François, Mick Gerard, Vercueil Laurent, Hodaj Enkelejda, Dumolard Anne, Noëlle Bénédicte, Delon-Martin Chantal, Lefaucheur Jean-Pascal
Centre de la Douleur, Pôle Anesthésie Réanimation, CHU Grenoble Alpes, 38000, Grenoble, France; Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000, Grenoble, France.
Centre de la Douleur, Pôle Anesthésie Réanimation, CHU Grenoble Alpes, 38000, Grenoble, France; Univ. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000, Grenoble, France.
Brain Stimul. 2022 Mar-Apr;15(2):441-453. doi: 10.1016/j.brs.2022.02.012. Epub 2022 Feb 25.
To assess the prophylactic effect of anodal tDCS of the left motor cortex in patients with resistant chronic migraine (CM) and its long-term maintenance.
In a patient-assessor blinded, sham-controlled trial, 36 patients were randomized to receive anodal tDCS (active group, n = 18) or sham tDCS (sham group, n = 18). The studied population was characterized by a previous failure of at least 3 classes of preventive drugs and a mean duration of migraine history of 26 years. The tDCS procedure consisted of an induction phase of 5 consecutive daily sessions (week 1) followed by a maintenance phase of 1 weekly session during the next 4 weeks and two bimonthly sessions in the next month, for a total of 11 sessions during 2 months. Anodal tDCS was delivered at 2 mA intensity for 20 min over the left motor cortex. The primary endpoint was the reduction in the monthly number of migraine attacks from baseline to each period of follow-up (months 1, 2, 3, 5) between the active and sham groups.
The monthly number of migraine attacks expressed as the percentage of reduction from baseline was significantly reduced in the active versus the sham group, from the end of first month (-21% ± 22 vs. -2% ±25, p = 0.019) to the end of follow-up (3-month post-treatment) (-32% ± 33 vs. -6% ±39, p = 0.011). At this time, the rate of responders, defined as a reduction of the monthly number of migraine attacks ≥30% from baseline, was significantly higher in the active group than in the sham group (50% vs. 14%, p = 0.043).
Our results show a marked prophylactic effect of anodal tDCS of the left motor cortex in resistant CM extending several months after the stimulation period, and suggest that this neuromodulatory approach may be part of the prophylactic alternatives available for CM.
评估左侧运动皮层阳极经颅直流电刺激(tDCS)对难治性慢性偏头痛(CM)患者的预防效果及其长期维持作用。
在一项患者和评估者双盲、假刺激对照试验中,36例患者被随机分为接受阳极tDCS组(治疗组,n = 18)或假tDCS组(假刺激组,n = 18)。研究人群的特征为至少3类预防性药物治疗失败且偏头痛病史平均持续26年。tDCS治疗程序包括连续5天的诱导期(第1周),随后在接下来的4周内每周进行1次维持治疗,在下个月每两个月进行1次治疗,在2个月内共进行11次治疗。阳极tDCS以2 mA强度在左侧运动皮层上施加20分钟。主要终点是治疗组和假刺激组从基线到各随访期(第1、2、3、5个月)每月偏头痛发作次数的减少情况。
与假刺激组相比,治疗组从基线减少的偏头痛发作次数百分比显著降低,从第一个月末(-21% ± 22 vs. -2% ± 25,p = 0.019)到随访结束(治疗后3个月)(-32% ± 33 vs. -6% ± 39,p = 0.011)。此时,定义为每月偏头痛发作次数较基线减少≥30%的有效率在治疗组显著高于假刺激组(50% vs. 14%,p = 0.043)。
我们的结果显示,左侧运动皮层阳极tDCS对难治性CM具有显著的预防作用,且在刺激期后数月仍持续存在,提示这种神经调节方法可能是CM可用预防方案的一部分。